AstraZeneca Recalls Merrem I.V. Vials Due to Precipitate Presence
AstraZeneca is recalling specific lots of Merrem I.V. (meropenem) because of precipitate presence, which may prevent the medication from mixing completely.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II, which corresponds to a Severe severity score under the rubric for significant potential harm or significant injury reports.
Plain-English summary
AstraZeneca Pharmaceuticals LP is recalling 81,900 vials of MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial. The recall affects NDC 0310-321-30, specifically lot JX109 and lot JY042, both with an expiration date of 2/2015. The product was distributed in the USA and Puerto Rico.
The recall was initiated due to the presence of precipitate in the vials. This condition creates a potential for incomplete constitution, meaning the medication may not mix properly when the diluent is added. The FDA has classified this recall as Class II.
Healthcare providers and patients should stop using the affected lots of Merrem I.V. and contact their pharmacist or the recalling firm for further instructions. Consumers should not attempt to use the product if they have identified the specific lot numbers and expiration dates listed in this notice.
The recalled product
- Product
- MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Category
- Drug — Antibiotic
- Affected units
- 81,900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- NDC 0310-321-30
- lot JX109
- expiration 2/2015
- lot JY042
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · AstraZeneca Pharmaceuticals LP
See all →- LowAstraZeneca Recalls Lynparza Capsules Due to Quality Attribute Deviation
FDA (Drugs) · 2018-03-14
- SevereAstraZeneca Recalls BRILINTA Tablets Due to Foreign Zurampic Contamination
FDA (Drugs) · 2017-07-19
- ModerateAstraZeneca Recalls Tudorza Pressair Inhalers Due to Defective Delivery System
FDA (Drugs) · 2016-03-30
- SevereNEXIUM Capsules Recalled Due to Presence of SEROQUEL XR Tablets
FDA (Drugs) · 2015-06-24
Same hazard · precipitate
See all →- HighMycophenolate Mofetil Injection Recalled Due to Precipitate in Vials
FDA (Drugs) · 2026-08-05
- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- ModerateUS Worldmeds Recalls Revonto Dantrolene Sodium Injection Due to Precipitate
FDA (Drugs) · 2019-05-08
- LowPromise Pharmacy Recalls Prednisolone and Gatifloxacin Ophthalmic Solution Due to Precipitate
FDA (Drugs) · 2018-10-31
- SevereSCA Pharmaceuticals Recalls Furosemide Injection Bags Due to Precipitate
FDA (Drugs) · 2018-09-19